LV11865B - COMPOSITIONS AND METHODS FOR TREATMENT OF BODY BODIES - Google Patents
COMPOSITIONS AND METHODS FOR TREATMENT OF BODY BODIES Download PDFInfo
- Publication number
- LV11865B LV11865B LVP-97-70A LV970070A LV11865B LV 11865 B LV11865 B LV 11865B LV 970070 A LV970070 A LV 970070A LV 11865 B LV11865 B LV 11865B
- Authority
- LV
- Latvia
- Prior art keywords
- cis
- acid diester
- cyclooctanediol
- compound
- piperazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C271/34—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31226994A | 1994-09-23 | 1994-09-23 | |
PCT/US1995/011814 WO1996009297A1 (fr) | 1994-09-23 | 1995-09-14 | Compositions et procedes de traitement de maladies inflammatoires provoquees par les mastocytes |
Publications (2)
Publication Number | Publication Date |
---|---|
LV11865A LV11865A (lv) | 1997-10-20 |
LV11865B true LV11865B (en) | 1998-01-20 |
Family
ID=23210670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-97-70A LV11865B (en) | 1994-09-23 | 1997-04-22 | COMPOSITIONS AND METHODS FOR TREATMENT OF BODY BODIES |
Country Status (25)
Country | Link |
---|---|
US (2) | US6022969A (fr) |
EP (1) | EP0782571A1 (fr) |
JP (1) | JPH10506390A (fr) |
KR (1) | KR970706267A (fr) |
CN (1) | CN1160398A (fr) |
AU (1) | AU694275B2 (fr) |
CA (1) | CA2200561A1 (fr) |
CZ (1) | CZ87097A3 (fr) |
EE (1) | EE03525B1 (fr) |
FI (1) | FI971171A (fr) |
HR (1) | HRP950499B1 (fr) |
HU (1) | HUT77770A (fr) |
IL (1) | IL115405A (fr) |
LT (1) | LT4234B (fr) |
LV (1) | LV11865B (fr) |
MX (1) | MX9702125A (fr) |
NO (1) | NO309605B1 (fr) |
NZ (1) | NZ294392A (fr) |
PL (1) | PL183552B1 (fr) |
RU (1) | RU2159229C2 (fr) |
SI (1) | SI9520101A (fr) |
SK (1) | SK37997A3 (fr) |
TW (1) | TW442478B (fr) |
WO (1) | WO1996009297A1 (fr) |
ZA (1) | ZA958028B (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL331465A1 (en) * | 1996-07-30 | 1999-07-19 | Axys Pharmaceuticals | Novel compounds and agents for treating diseases associated with triptase activity |
WO1998024886A1 (fr) * | 1996-12-04 | 1998-06-11 | Brigham And Women's Hospital, Inc. | Protease issue de mastocytes clivant le fibrogene |
US5955431A (en) * | 1997-02-05 | 1999-09-21 | Brigham And Women's Hospital, Inc. | Mast cell protease peptide inhibitors |
AU8997498A (en) * | 1997-09-05 | 1999-03-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitor |
US6221914B1 (en) * | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
EP1030844A1 (fr) * | 1997-11-10 | 2000-08-30 | Array Biopharma Inc. | Composes inhibant l'activite de la tryptase |
EP1060171A2 (fr) * | 1998-02-06 | 2000-12-20 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Inhibiteurs de la tryptase |
WO1999040083A2 (fr) * | 1998-02-06 | 1999-08-12 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Inhibiteurs de la tryptase |
WO2000014097A2 (fr) * | 1998-09-04 | 2000-03-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Nouvelles pyranoses |
US6362216B1 (en) | 1998-10-27 | 2002-03-26 | Array Biopharma Inc. | Compounds which inhibit tryptase activity |
US6849605B1 (en) * | 1999-03-05 | 2005-02-01 | The Trustees Of University Technology Corporation | Inhibitors of serine protease activity, methods and compositions for treatment of viral infections |
AU3731400A (en) * | 1999-03-05 | 2000-09-21 | Trustees Of University Technology Corporation, The | Methods and compositions useful in inhibiting apoptosis |
ES2230155T3 (es) * | 1999-08-10 | 2005-05-01 | Altana Pharma Ag | Derivados de diazocin-diona y su uso como inhibidores de triptasa. |
US6960588B1 (en) | 1999-09-14 | 2005-11-01 | Altana Pharma Ag | Tryptase inhibitors |
GB9923710D0 (en) * | 1999-10-08 | 1999-12-08 | Proteus Molecular Design | Chemical compounds |
WO2001036386A1 (fr) * | 1999-11-17 | 2001-05-25 | Sumitomo Pharmaceuticals Co., Ltd. | Traitement du diabete contenant un derive de dipiperazine |
JP2003518109A (ja) * | 1999-12-20 | 2003-06-03 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼ阻害剤 |
DE60011300T2 (de) | 1999-12-20 | 2005-08-04 | Altana Pharma Ag | Inhibitoren der tryptase |
WO2001052883A1 (fr) * | 2000-01-20 | 2001-07-26 | Amgen Inc. | Inhibiteurs du recepteur-2 active par une protease (par-2) utilises comme nouveaux agents therapeutiques contre l'asthme |
US20020045613A1 (en) * | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
PT1358182E (pt) * | 2001-01-31 | 2004-12-31 | Altana Pharma Ag | Derivados de diazocinas e sua utilizacao como inibidores de triptase |
DE60220504T2 (de) | 2001-02-21 | 2008-02-14 | Nycomed Gmbh | Tryptasehemmer |
AU2002253035B8 (en) | 2001-02-21 | 2008-02-21 | Altana Pharma Ag | Tryptase inhibitors |
EP1370518A2 (fr) * | 2001-03-15 | 2003-12-17 | ALTANA Pharma AG | Inhibiteurs de la tryptase |
WO2002074732A2 (fr) * | 2001-03-15 | 2002-09-26 | Altana Pharma Ag | Inhibiteurs de la tryptase |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) * | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6818787B2 (en) * | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7232924B2 (en) * | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
JP2005508871A (ja) | 2001-06-19 | 2005-04-07 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼインヒビター |
CA2469607A1 (fr) * | 2001-12-13 | 2003-06-19 | Kowa Company, Ltd. | Composition pharmaceutique destinee a la prevention ou au traitement de l'hypersensibilite retardee |
EP1483241A4 (fr) | 2002-03-08 | 2006-12-13 | Bristol Myers Squibb Co | Derives cycliques servant de modulateurs de l'activite du recepteur de la chimiokine |
TW200524849A (en) * | 2003-07-02 | 2005-08-01 | Hoffmann La Roche | Hydroxyalkylamide derivatives |
US20050255154A1 (en) * | 2004-05-11 | 2005-11-17 | Lena Pereswetoff-Morath | Method and composition for treating rhinitis |
TW200815351A (en) * | 2006-05-02 | 2008-04-01 | Astrazeneca Ab | Novel compounds |
TWI414527B (zh) * | 2010-10-06 | 2013-11-11 | Ind Tech Res Inst | 異山梨糖醇衍生物及包含該衍生物之液晶顯示器 |
CN102453037B (zh) * | 2010-10-25 | 2014-06-25 | 财团法人工业技术研究院 | 异山梨糖醇衍生物及包含该衍生物的液晶显示器 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR208414A1 (es) * | 1974-11-07 | 1976-12-27 | Rhone Poulenc Ind | Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2) |
US4746737A (en) * | 1985-07-26 | 1988-05-24 | Kowa Co., Ltd. | Phenyl guanidinobenzoate derivatives which have protease inhibitory activity |
US5525623A (en) * | 1993-03-12 | 1996-06-11 | Arris Pharmaceutical Corporation | Compositions and methods for the treatment of immunomediated inflammatory disorders |
PL176941B1 (pl) * | 1993-03-12 | 1999-08-31 | Axys Pharmaceuticals | Nowe peptydy i środek farmaceutyczny do leczenia immunologicznych stanów zapalnych |
DE69514798D1 (de) * | 1994-06-01 | 2000-03-02 | Axys Pharm Inc | Zusammensetzungen und verfahren zur behandlung von durch mast-zellen verursachten krankheiten |
-
1995
- 1995-09-14 WO PCT/US1995/011814 patent/WO1996009297A1/fr not_active Application Discontinuation
- 1995-09-14 AU AU37180/95A patent/AU694275B2/en not_active Ceased
- 1995-09-14 CA CA002200561A patent/CA2200561A1/fr not_active Abandoned
- 1995-09-14 EP EP95934993A patent/EP0782571A1/fr not_active Withdrawn
- 1995-09-14 NZ NZ294392A patent/NZ294392A/xx unknown
- 1995-09-14 CN CN95195191A patent/CN1160398A/zh active Pending
- 1995-09-14 US US08/522,157 patent/US6022969A/en not_active Expired - Fee Related
- 1995-09-14 MX MX9702125A patent/MX9702125A/es not_active IP Right Cessation
- 1995-09-14 HU HU9702059A patent/HUT77770A/hu unknown
- 1995-09-14 SK SK379-97A patent/SK37997A3/sk unknown
- 1995-09-14 SI SI9520101A patent/SI9520101A/sl unknown
- 1995-09-14 EE EE9700089A patent/EE03525B1/xx not_active IP Right Cessation
- 1995-09-14 CZ CZ97870A patent/CZ87097A3/cs unknown
- 1995-09-14 KR KR1019970701960A patent/KR970706267A/ko not_active Application Discontinuation
- 1995-09-14 JP JP8511002A patent/JPH10506390A/ja not_active Ceased
- 1995-09-14 RU RU97106347/04A patent/RU2159229C2/ru not_active IP Right Cessation
- 1995-09-14 PL PL95319587A patent/PL183552B1/pl unknown
- 1995-09-22 ZA ZA958028A patent/ZA958028B/xx unknown
- 1995-09-22 HR HR950499A patent/HRP950499B1/xx not_active IP Right Cessation
- 1995-09-22 IL IL11540595A patent/IL115405A/en not_active IP Right Cessation
- 1995-09-26 TW TW084110031A patent/TW442478B/zh active
-
1997
- 1997-03-20 NO NO971305A patent/NO309605B1/no unknown
- 1997-03-20 FI FI971171A patent/FI971171A/fi unknown
- 1997-04-10 LT LT97-065A patent/LT4234B/lt not_active IP Right Cessation
- 1997-04-22 LV LVP-97-70A patent/LV11865B/en unknown
-
1999
- 1999-03-29 US US09/280,227 patent/US6211228B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6211228B1 (en) | 2001-04-03 |
JPH10506390A (ja) | 1998-06-23 |
TW442478B (en) | 2001-06-23 |
PL183552B1 (pl) | 2002-06-28 |
WO1996009297A1 (fr) | 1996-03-28 |
US6022969A (en) | 2000-02-08 |
HUT77770A (hu) | 1998-08-28 |
ZA958028B (en) | 1996-04-18 |
SI9520101A (en) | 1997-12-31 |
CA2200561A1 (fr) | 1996-03-28 |
NO309605B1 (no) | 2001-02-26 |
PL319587A1 (en) | 1997-08-18 |
EE03525B1 (et) | 2001-10-15 |
NO971305D0 (no) | 1997-03-20 |
NO971305L (no) | 1997-05-06 |
EP0782571A1 (fr) | 1997-07-09 |
RU2159229C2 (ru) | 2000-11-20 |
SK37997A3 (en) | 1998-12-02 |
FI971171A0 (fi) | 1997-03-20 |
FI971171A (fi) | 1997-03-20 |
AU3718095A (en) | 1996-04-09 |
KR970706267A (ko) | 1997-11-03 |
HRP950499A2 (en) | 1997-08-31 |
NZ294392A (en) | 1999-05-28 |
EE9700089A (et) | 1997-10-15 |
MX9702125A (es) | 1998-04-30 |
LT97065A (en) | 1997-08-25 |
IL115405A (en) | 2002-07-25 |
LV11865A (lv) | 1997-10-20 |
AU694275B2 (en) | 1998-07-16 |
IL115405A0 (en) | 1995-12-31 |
HRP950499B1 (en) | 2003-04-30 |
CZ87097A3 (en) | 1997-11-12 |
CN1160398A (zh) | 1997-09-24 |
LT4234B (en) | 1997-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU694275B2 (en) | Compositions and methods for treating mast-cell inflammatory conditions | |
US5656660A (en) | Compositions and methods for treating mast-cell mediated conditions | |
US5700801A (en) | Piperazine derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them | |
US6420438B1 (en) | 1-amino-7-isoquinoline derivatives as serine protease inhibitors | |
WO1992008709A1 (fr) | Derives de la phenylalanine metasubstitues | |
US4873253A (en) | Phenylalanine derivative and proteinase inhibitor | |
CA2098158A1 (fr) | Derives de biphenyles, compositions pharmaceutiques qui contiennent ces composes et leur mode de preparation | |
CZ29799A3 (cs) | Disubstituovaná cyklická sloučenina, způsob její výroby, farmaceutický přípravek a způsob léčení onemocnění živočicha | |
JP2002502850A (ja) | トリプターゼ阻害物質 | |
EP1244643B1 (fr) | Inhibiteurs de tryptase | |
US6673786B1 (en) | Tryptase inhibitors | |
EP1368317B1 (fr) | Inhibiteurs de tryptase | |
JP2004517943A (ja) | ジアゾシン誘導体およびトリプターゼインヒビターとしてのその使用 | |
JP2005535685A (ja) | トリプターゼ阻害剤としてのピロリジン誘導体 |